Suppr超能文献

携带人类肠道微生物群的小鼠发生多重耐药定植后的肠道和全身免疫反应

Intestinal and Systemic Immune Responses upon Multi-drug Resistant Colonization of Mice Harboring a Human Gut Microbiota.

作者信息

von Klitzing Eliane, Ekmekciu Ira, Bereswill Stefan, Heimesaat Markus M

机构信息

Institute of Microbiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Microbiology and Hygiene, Berlin, Germany.

出版信息

Front Microbiol. 2017 Dec 22;8:2590. doi: 10.3389/fmicb.2017.02590. eCollection 2017.

Abstract

The World Health Organization has rated multi-drug resistant (MDR) as serious threat for human health. It is, however, unclear, whether intestinal MDR carriage is associated with inflammatory responses in intestinal or even systemic compartments. In the present study, we generated with respect to their microbiota "humanized" mice by human fecal microbiota transplantation of secondary abiotic mice. Following peroral challenge with a clinical isolate on two consecutive days, mice harboring a human or murine microbiota were only partially protected from stable intestinal colonization given that up to 78% of mice were -positive at day 28 post-infection (p.i.). Irrespective of the host-specificity of the microbiota, colonized mice were clinically uncompromised. However, colonization resulted in increased intestinal epithelial apoptosis that was accompanied by pronounced proliferative/regenerative cell responses. Furthermore, at day 7 p.i. increased innate immune cell populations such as macrophages and monocytes could be observed in the colon of mice harboring either a human or murine microbiota, whereas this held true at day 28 p.i. for adaptive immune cells such as B lymphocytes in both the small and large intestines of mice with murine microbiota. At day 7 p.i., pro-inflammatory cytokine secretion was enhanced in the colon and mesenteric lymph nodes, whereas the anti-inflammatory cytokine IL-10 was down-regulated in the former at day 28 p.i. Strikingly, cytokine responses upon intestinal colonization were not restricted to the intestinal tract, but could also be observed systemically, given that TNF and IFN-γ concentrations were elevated in spleens as early as 7 days p.i., whereas splenic IL-10 levels were dampened at day 28 p.i. of mice with human microbiota. In conclusion, mere intestinal carriage of MDR by clinically unaffected mice results in pro-inflammatory sequelae not only in intestinal, but also systemic compartments.

摘要

世界卫生组织已将多重耐药(MDR)评定为对人类健康的严重威胁。然而,目前尚不清楚肠道MDR携带是否与肠道甚至全身各部位的炎症反应相关。在本研究中,我们通过对无菌小鼠进行人粪便微生物群移植,构建了具有人微生物群的“人源化”小鼠。在连续两天经口用临床分离株攻击后,携带人或鼠微生物群的小鼠仅部分免受稳定的肠道定植,因为在感染后第28天(p.i.)高达78%的小鼠呈阳性。无论微生物群的宿主特异性如何,定植小鼠的临床状况均未受损。然而,定植导致肠道上皮细胞凋亡增加,并伴有明显的增殖/再生细胞反应。此外,在感染后第7天,在携带人或鼠微生物群的小鼠结肠中可观察到先天免疫细胞群体如巨噬细胞和单核细胞增加,而在感染后第28天,对于具有鼠微生物群的小鼠,在小肠和大肠中,适应性免疫细胞如B淋巴细胞也出现这种情况。在感染后第7天,结肠和肠系膜淋巴结中的促炎细胞因子分泌增强,而在感染后第28天,前者中的抗炎细胞因子IL-10下调。值得注意的是,肠道定植后的细胞因子反应不仅限于肠道,在全身也可观察到,因为早在感染后7天,脾脏中的TNF和IFN-γ浓度就升高了,而在具有人微生物群的小鼠感染后第28天,脾脏中的IL-10水平降低。总之,临床上未受影响的小鼠单纯肠道携带MDR不仅会在肠道,还会在全身各部位导致炎症后遗症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0319/5744425/ba787c09b099/fmicb-08-02590-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验